Severe Infection

Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections: N-Acetylcysteine

CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit

Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections

Mechanisms of Prognostic Regulation andPrecision Phenotype Ldentification in Severe Infections Driven by SpecializedPro-Resolving Mediators

CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients

Construction and Validation of a Tool for Automatic Identification of Care Pathways At Risk of Sub-optimality in the Management of Severe Infections in Children (DIABACT IV)

Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care Unit

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections

Invasive Group A Streptococcal Infection

PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.

Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model

Evaluation of Pharmacokinetic / Pharmacodynamic Data and Interest Individualized Therapeutic Drug Monitoring Glycopeptides and β-lactam-aminoglycoside ICU

Phage Safety Cohort Study

Nutritional Supplement for Patients With Severe Infection

Validation of the Quick Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) in Obstetric Patients

Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis

Evaluation of MDW for Early Detection of Sepsis, Clinical Validity